In summary, our findings demonstrated that GSCs and GBM tumors exhibited differential cell-intrinsic type I and type II IFN/STAT1 signaling, and that high IFN signaling was associated with mesenchymal phenotype and poor survival outcomes. Here, STAT1 is linked to glioblastoma.